This event has ended. View the official site or create your own event → Check it out
This event has ended. Create your own
Welcome to the agenda for the 2013 MassDevice Big 100 West. All the pertinent event information logistics and updates will be hosted here.

If this is your first event, please take note that our program is rather unique. Our program is split into three portions.

First, we have educational sessions from 4:00-5:30. We call these our "Sparking the Conversation" sessions. These are generally panel discussions on hot button issues that med tech companies are facing, featuring executives and experts in each particular discipline. These sessions are concurrent, so you’ll have to pick one.

Second, we have a networking mixer with food and drinks so you can connect and re-connect with friends in the industry.

Finally, we have our main event featuring our CEO interviews. On December 10th we’ll hear from Dr. Robert Greenberg on the amazing rise of the "bionic eye," followed by a fascinating panel on the future of chronic diseases featuring C-level executives from ResMed, St. Jude Medical and Glooko. You can find information below on all those panels.

That’s all we have for now. Please make sure to reach out to the people you want to connect with and, as always, you can contact me with any questions.

View analytic
Tuesday, December 10 • 4:00pm - 5:30pm
Size Does Not Matter: Medtech Companies at Risk of Government Enforcement

Sign up or log in to save this to your schedule and see who's attending!

Regardless of your company’s size, there are laws and regulations you cannot and should not ignore.  The risk of government scrutiny by the enforcement community is just too great.  Various government agencies - DOJ, OIG, FDA and SEC (to name a few) – have taken action and almost certainly will continue to take action against medical device companies for false claims violations, kickbacks, bribery and corruption, and off-label promotion.  The risk of financial and other penalties for companies and their executives can be significant and can put a growing company in serious jeopardy, financially and otherwise.


There are some basic and reasonable steps companies can and should take to prevent compliance missteps and limit their risk.  This session with Porzio Life Sciences and medtech industry leaders will help companies understand the risks and what they can do to address these risks so they can continue to effectively run and grow their businesses.


avatar for Michelle Axelrod

Michelle Axelrod

Principal, Porzio LifeSciences
Michelle Axelrod brings over 15 years of in-house experience at leading life sciences and related healthcare organizations to her role as Principal, Porzio, Bromberg & Newman and Vice President, Porzio Life Sciences. Michelle offers valuable insights and provides innovative ideas to support business goals while effectively protecting companies and reducing organizational risk. She counsels pharmaceutical, medical device and biotech clients on... Read More →


Diane Biagianti

VP, Chief Responsibility Officer, Edwards Lifesciences
Diane W. Biagianti is Vice President, Chief Responsibility Officer at Edwards Lifesciences LLC where she has responsibility for the company’s Ethics and Compliance program.  Prior to joining Edwards, Ms. Biagianti served as Divisional Vice President, Legal, for Abbott Medical Optics, Inc. from 2009 to 2011.  She formerly served as Senior Vice President, General Counsel and Assistant Secretary of Advanced Medical Optics, Inc... Read More →

Michael Crompton

VP, RA/QA, Chief Compliance Officer, Revision Optics, Inc.

Ed Crowe

Director, Porzio LifeSciences
avatar for Adam  Krauss

Adam Krauss

Associate General Counsel, Covidien

Tuesday December 10, 2013 4:00pm - 5:30pm
Hyatt Regency Irvine 17900 Jamboree Rd, Irvine, CA 92614

Attendees (2)